I agree with your thinking and know thats the research thats invested in. But this companys management leaves me to believe that they care about themselves and not the reasearch or doing trials. Their money is limited, and with the timeline for phase 3, they will run out of money. They have about 50 million now, they wont have enough for the proper studies, and instead let it run and bleed into their own pockets. This company needs to change management and be more agressive with their data. This is the only way it will succeed, otherwise it will fall to 30 cents and die a slow death.